C/EBPβ expression in activated microglia in amyotrophic lateral sclerosis

Area of Science:

• Neuroscience
• Immunology
• Genetics

Background:

• Neuroinflammation is implicated in neurodegenerative diseases like amyotrophic lateral sclerosis (ALS).
• Microglia, the immune cells of the central nervous system, play a key role in neuroinflammation.

Purpose of the Study:

• To investigate the role of microglial activation and specific transcription factors in the neuroinflammatory response in an ALS animal model.
• To determine if CCAAT/enhancer binding protein β (C/EBPβ) is involved in microglial-driven neuroinflammation in ALS.

Main Methods:

• Comparison of microglial cultures from G93A-SOD1 mice (ALS model) and wild-type mice.
• Induction of inflammation using lipopolysaccharide (LPS) and interferon-γ.
• Analysis of inflammatory markers including nitric oxide synthase-2 (NOS2), cyclooxygenase-2 (COX-2), and C/EBPβ expression.
• In vivo studies in G93A-SOD1 mice and analysis of spinal cord tissue from ALS patients.

Main Results:

• G93A-SOD1 microglial cells showed higher expression of NOS2 and COX-2 upon LPS/interferon-γ stimulation compared to wild-type.
• CCAAT/enhancer binding protein β (C/EBPβ) levels were upregulated in activated G93A-SOD1 microglia.
• Systemic LPS administration induced a more severe neuroinflammatory response in G93A-SOD1 mice.
• C/EBPβ was found in microglia in the spinal cords of ALS patients, a novel finding in human disease.

Conclusions:

• G93A-SOD1 expression leads to an amplified neuroinflammatory response in microglia.
• CCAAT/enhancer binding protein β (C/EBPβ) is a key transcription factor upregulated in ALS-associated microglial activation.
• C/EBPβ is a potential regulator of neurotoxic gene expression in microglia during ALS pathogenesis.